The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Huoxiang Zhengqi For Covid 19 Market By The End Of 2030?
The huoxiang zhengqi for covid 19 market size has seen significant expansion in recent years. It is projected to increase from $1.54 billion in 2025 to $1.73 billion in 2026, showcasing a compound annual growth rate (CAGR) of 12.1%. The growth observed in the past can be primarily ascribed to factors such as a high reliance on traditional medicine during health emergencies, government support for TCM throughout covid-19, limited initial pharmaceutical solutions, a cultural preference for herbal remedies, and a rapid surge in demand during pandemic waves.
The huoxiang zhengqi for covid 19 market size is anticipated to undergo swift expansion over the next few years. It is projected to reach $2.72 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.1%. The expansion during this forecast period can be attributed to sustained interest in therapies supporting the immune system, the spread of integrative medicine practices, a burgeoning consumer base focused on health, the development of herbal pharmaceutical production, and increasing investigation into traditional formulations. Significant trends expected during the forecast period include the growing embrace of traditional Chinese medicine, a rise in the application of herbal formulations for immune support, the broader use of preventive healthcare solutions, increasing incorporation with conventional covid therapies, and a surging demand for remedies promoting digestive and immune health.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24246&type=smp
Which Market Drivers Are Supporting The Expansion Of The Huoxiang Zhengqi For Covid 19 Market?
The increasing demand for herbal medicine is expected to propel the growth of the Huoxiang Zhengqi for COVID-19 market going forward. Herbal medicine involves the use of plants or plant-derived substances for therapeutic or medicinal purposes to prevent, treat, or manage various health conditions. This rising demand for herbal medicine is primarily driven by consumers’ growing preference for natural, plant-based remedies over synthetic drugs, attributed to perceived safety, fewer side effects, and comprehensive health benefits. Huoxiang Zhengqi for COVID-19 aids herbal medicine by providing a traditional remedy that supports immune function, alleviates symptoms, and promotes recovery, thus demonstrating the potential role of herbal therapies in managing viral infections. For instance, in September 2024, according to the HerbalGram, a US-based nonprofit organization, the total annual sales of herbal dietary supplements rose from $12.018 billion in 2022 to $12.551 billion in 2023, reflecting a growth of 4.4%. Therefore, the increasing demand for herbal medicine is driving the growth of the Huoxiang Zhengqi for COVID-19 market.
Which Segment Classifications Shape The Huoxiang Zhengqi For Covid 19 Market?
The huoxiang zhengqi for covid 19 market covered in this report is segmented –
1) By Product Type: Liquid, Pills, Granules, Other Product Types
2) By Consumers: Health-Conscious Consumers, Individuals Seeking Immunity Support, Alternative Medicine Enthusiasts, Parents Purchasing For Children
3) By Usage Occasions: Preventive Health Use, During COVID 19 Symptoms, Post-Recovery Health Management, Seasonal Illness Protection
4) By Application: Hospitals, Clinics, Home Care, Other Applications
5) By Distribution Chanel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Chanels
Subsegments:
1) By Liquid: Oral Liquid, Injectable Liquid
2) By Pills: Tablets, Capsules
3) By Granules: Single-Dose Granules, Multi-Dose Granules
4) By Other Product Types: Syrup, Powder For Solution
How Are Trends Impacting The Huoxiang Zhengqi For Covid 19 Market?
Leading companies within the Huoxiang Zhengqi for COVID-19 market sector are concentrating on introducing novel private-label formulations, such as Huoxiang Zhengqi oral liquid products. These are modernized liquid versions of the traditional Huoxiang Zhengqi herbal formula, developed to enhance convenience, ensure precise dosing, and facilitate quick absorption. An illustration of this trend is YSB Inc., a pharmaceutical retail and healthcare services firm based in China, unveiling the Leyaoshi Huoxiang Zhengqi Oral Liquid in June 2024. This product boasts a single-dose, ready-to-drink liquid configuration, offers fast-acting digestive and anti-dampness relief, and its composition is tailored for seasonal gastrointestinal issues.
Which Companies Are Expanding Their Footprint In The Huoxiang Zhengqi For Covid 19 Market?
Major companies operating in the huoxiang zhengqi for covid 19 market are Yunnan Baiyao Group Co. Ltd., Beijing Tongrentang Co. Ltd., Taiji Group Chongqing Fuling Pharmaceutical Factory Co. Ltd., Tasly Pharmaceutical Group Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., Guizhou Sanli Pharmaceutical Co. Ltd., China Shineway Pharmaceutical Group Limited, Zhangzhou Pientzehuang Pharmaceutical Co. Ltd., Wuhu Zhanghengchun Medicine Co. Ltd., Tonghua Dongbao Pharmaceutical Co. Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd., Sichuan Neo-Green Pharmaceutical Technology Co. Ltd., Hutchison China MediTech Limited, Shijiazhuang Yiling Pharmaceutical Co. Ltd., Jilin Aodong Pharmaceutical Group Co. Ltd., Livzon Pharmaceutical Group Inc., China Traditional Chinese Medicine Holdings Co. Ltd., Kunming Pharmaceutical Corp., Guangdong Yifang Pharmaceutical Co. Ltd., Jiangyin Tianjiang Pharmaceutical Co. Ltd.
Read the full huoxiang zhengqi for covid 19 market report here:
https://www.thebusinessresearchcompany.com/report/huoxiang-zhengqi-for-covid-19-global-market-report
How Is The Huoxiang Zhengqi For Covid 19 Market Distributed Across Key Geographic Regions?
Asia-Pacific was the largest region in the Huoxiang Zhengqi for COVID-19 market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the huoxiang zhengqi for covid 19 market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Huoxiang Zhengqi For Covid 19 Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24246&type=smp
Browse Through More Reports Similar to the Global Huoxiang Zhengqi For Covid 19 Market 2026, By The Business Research Company
Coronavirus Current Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report
Covid 19 Rapid Test Kits Market 2026
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market
Covid 19 Antigen Test Market Report 2026
https://www.thebusinessresearchcompany.com/report/covid-19-antigen-test-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model